Thirty percent of clinical trial sites that open for enrollment enroll zero patients before the study closes. Not one. This is one of the most consistent findings in clinical research operations data, and it has nothing to do with patient availability in the treatment area. It has everything to do with the absence of a system.
Sites that enroll zero patients typically open with the same general plan: the principal investigator will refer patients from their own practice, word will spread through the local physician community, and the site will meet its enrollment numbers. That plan works occasionally. When it fails — and it fails at a documented rate of 30 percent — it fails completely.
The Structural Problem Is Not Patient Scarcity
Most clinical trials fail to recruit on time because of a flawed assumption at the planning stage: that a PI's existing patient panel and informal referral network will generate enough volume to hit targets. Research from multiple sources confirms that 80 to 85 percent of clinical trials fail to meet initial enrollment projections. The sites that hit zero are not in unusually thin patient markets. They are sites that have no mechanism to reach the full population of eligible patients — or the physicians treating those patients — in their geographic area.
The addressable patient population for most therapeutic areas is far larger than a single physician's panel. A site running a type 2 diabetes trial may be located in a region with thousands of eligible patients — but they are spread across dozens of primary care practices, endocrinologists, and urgent care clinics whose physicians have no relationship with the research site and no reason to refer unless someone reaches out directly.
What Sites With Strong Enrollment Records Do Before Study Activation
Sites that consistently hit enrollment targets have one thing in common: they do not wait until after site initiation to start building referral volume. They identify every physician of the relevant specialty within their geographic radius, establish contact before the study opens, and have an active referral pipeline generating inbound patient inquiries by the time they can consent their first participant.
This is not a passive process. It requires knowing which physicians are treating the relevant patient population — by specialty taxonomy code, geographic radius from the site, and practice size — and reaching them directly with protocol information in a format they can act on. The sites that hit zero patients are waiting. The sites that hit their targets are outreaching.
The Cost of Zero Enrollment Beyond the Current Study
A site that enrolls zero patients on one study does not simply miss one opportunity. Sponsors and CROs track historical enrollment performance and use it as the primary predictor of future performance. A site with a zero-enrollment record gets deprioritized for future feasibility questionnaires, which means fewer studies offered, which means less revenue, which means less capacity to invest in the outreach infrastructure that drives enrollment. The compounding effect is documented and significant.
Sites that break out of zero-enrollment patterns typically do so by building an external outreach infrastructure — systematic physician identification, automated outreach sequences, and a documented referral pipeline — before accepting another study. The infrastructure investment comes before the study revenue, not after it.
The NPI Registry and the Geographic Reality
The CMS National Provider Identifier (NPI) Registry is a publicly available federal database of every licensed US physician, searchable by specialty taxonomy code and geographic location. For a site running a rheumatology trial, a query for rheumatologist taxonomy codes within a 25-mile radius of the site address typically returns 50 to 300 physicians — far more than any PI knows personally. These are physicians currently treating patients who meet the study's inclusion criteria. None of them will refer without being contacted directly.
The 30 percent zero-enrollment rate exists because sites are not using the data that is publicly available to build systematic outreach. The solution is not complicated. It requires having the process in place to identify, contact, and maintain relationships with referring physicians before enrollment pressure arrives.